Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Gastrointestinal Bleeding, Emergency Medicine


Basics


Description


  • Bleeding from GI tract:
    • Upper GI tract: Proximal to ligament of Treitz
    • Lower GI tract: Distal to ligament of Treitz to anus
  • Mortality rate:
    • 10% overall; from <5% in children up to 25% for adults of age >70
    • Upper GI bleed (UGIB) 6-8%; variceal 30-50%
    • Lower GI bleed (LGIB) 2-4%

Etiology


Upper GI Bleed (UGIB):
  • Ulcerative disease of upper GI tract:
    • Peptic ulcer disease (40%):
      • Helicobacter pylori infection
      • Drug-induced (NSAIDs, aspirin, glucocorticoids, K+ supplements, Fe supplements)
    • Gastric or esophageal erosions (25%):
      • Reflux esophagitis
      • Infectious esophagitis (Candida, HSV, CMV)
      • Pill-induced esophagitis
      • Esophageal foreign body
    • Gastritis and stress ulcerations:
      • Toxic agents (NSAIDs, alcohol, bile)
      • Mucosal hypoxia (trauma, burns, sepsis)
      • Cushing ulcers from severe CNS damage
      • Chemotherapy
  • Portal HTN:
    • Esophageal or gastric varices (10%)
    • Portal hypertensive gastropathy
  • Arteriovenous malformations:
    • Aortoenteric fistula (s/p aortoiliac surgery)
    • Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)
    • Dieulafoy vascular malformations
    • Gastric antral vascular ectasia (GAVE or watermelon stomach)
    • Idiopathic angiomas
  • Mallory-Weiss tear (5%)
  • Gastric and esophageal tumors
  • Pancreatic hemorrhage
  • Hemobilia
  • Strongyloides stercoralis infection

Lower GI Bleed (LGIB):
  • Diverticulosis (33%)
  • Cancer or polyps (19%)
  • Colitis (18%):
    • Ischemic, inflammatory, infectious, or radiation
  • Vascular:
    • Angiodysplasia (8%)
    • Radiation telangiectasia
    • Aortocolonic fistula
  • Inflammatory bowel disease:
    • Crohns disease and ulcerative colitis
  • Postpolypectomy
  • Anorectal (4%):
    • Hemorrhoids (internal and external)
    • Anal fissures
    • Anorectal varices
    • Rectal ulcer
    • Foreign body

Meckel diverticulum and intussusception are the most common causes of LGIB in children.  

Diagnosis


Signs and Symptoms


  • Both UGIB and LGIB may present with signs/symptoms of hypovolemia
  • UGIB classic presentation:
    • Hematemesis or coffee ground emesis
    • Melena: Black tarry stool
  • LGIB classic presentation:
    • Hematochezia: Bright red or maroon stool

Hematochezia classically signals an LGIB, but can also be seen with brisk UGIB.  
History
  • Hematemesis and melena most common
  • Coffee ground emesis
  • Black stools
  • Bright red blood per rectum
  • Abdominal pain
  • Weakness or lightheadedness
  • Dyspnea
  • Confusion or agitation

Physical Exam
  • Tachycardia
  • Hypotension
  • Pale conjunctiva
  • Dry mucous membranes
  • Bloody, melanotic, or heme-positive stools
  • Shock

Essential Workup


  • CBC, coagulation studies, electrolytes
  • Perform ENT exam. Distinguish between hemoptysis and hematemesis:
    • Pulmonary source:
      • Bright red and frothy in appearance
      • Sputum mixed with blood is likely pulmonary
      • pH >7
    • GI source:
      • Dark red/brown blood, ± gastric contents
      • Associated with nausea/vomiting
      • pH <7
  • Consider nasogastric lavage:
    • Might help determine if bleeding is ongoing and facilitate endoscopy
    • Controversialstudies have failed to demonstrate outcome benefit. False-negatives, if bleeding beyond pylorus.
  • Rectal exam:
    • Inspect for hemorrhoids and anal fissures
    • Examine stool color
    • False-positive Hemoccult result:
      • Raw red meat
      • Iron supplements
      • Fruits: Cantaloupe, grapefruit, figs
      • Vegetables: Raw broccoli, cauliflower, radish
      • Methylene blue, chlorophyll
      • Iodide, bromide
    • False-negative Hemoccult result:
      • Bile
      • Mg-containing antacids
      • Ascorbic acid
    • Agents causing black stools, but negative Hemoccult:
      • Iron
      • Charcoal
      • Bismuth (i.e., Pepto-Bismol)
      • Food dyes
      • Beets

Bloody stool in newborns may be caused by the infant swallowing maternal blood.  

Diagnosis Tests & Interpretation


Lab
  • CBC:
    • Anemia (low mean corpuscular volume seen with chronic blood loss)
    • Thrombocytopenia
  • Electrolytes, BUN, creatinine, glucose
  • Coagulation profile
  • Lactate
  • LFTs, if upper GI bleeding suspected
  • Type and screen/cross for active bleeding or unstable vital signs
  • BUN/Cr ratio >36 has a high sensitivity but low specificity for UGIB

Hematocrit can remain normal for a period after acute blood loss; a drop may not be immediately seen.  
Imaging
  • Upright CXR if concern for aspiration or perforation
  • Angiography/arterial embolization:
    • Effective for identifying large, active bleeding
  • Radionucleotide (tagged red blood cell) scan:
    • Effective for identifying slow, active bleeding

Diagnostic Procedures/Surgery
  • Anoscopy:
    • For suspected internal hemorrhoids or fissures
  • Esophagogastroduodenoscopy (EGD):
    • Diagnostic and possibly therapeutic
  • Colonoscopy:
    • Diagnostic only
    • Best after adequate bowel prep
  • Bowel resection:
    • Reserved for refractory bleeding

Differential Diagnosis


  • Epistaxis
  • Oropharyngeal bleeding
  • Hemoptysis
  • Hematuria
  • Vaginal bleeding
  • Visceral trauma

Treatment


Pre-Hospital


  • Stabilize airway
    • Intubate for massive UGIB, if patient unable to protect airway
  • Establish access
    • Insert large-bore IV (16-18g) and administer crystalloid to keep SBP >90 mm Hg
    • Attempt 2nd IV line en route to hospital

Initial Stabilization/Therapy


  • Assess airway, breathing, and circulation
  • Control airway in unstable patients, with massive bleeding, or unable to protect airway
  • Initiate 2 large-bore (16 g) IVs and place on cardiac monitor
  • Provide volume:
    • Administer 1 L NS bolus (peds: 20 mL/kg) and repeat once, if necessary
    • Transfuse RBCs if significant anemia or unstable after crystalloid boluses
      • Cross-matched or type-specific blood, if available
      • Otherwise, O negative for premenopausal women, O positive for others
      • Provide fresh frozen plasma (FFP) along with RBC transfusion in ratio of 1:2-4. For patients requiring massive transfusion, consider adding FFP and platelets in 1:1:1 ratio with RBCs
    • For coagulopathy, administer FFP and vitamin K (if INR >1.5) and platelets (if platelets <50,000/uL)

Ed Treatment/Procedures


  • Consult gastroenterology for any significant GI bleeding
  • Consider surgical consult and/or interventional radiology for massive active bleeding, unstable patient, or evidence of perforation
  • Place Foley catheter to monitor urine output
  • Consider nasogastric tube (NGT), as above
  • Blood transfusion indications:
    • Significant anemia:
      • Hemoglobin <7 g/dL
      • Hemoglobin <10 g/dL when at increased risk of ischemia (e.g., CAD and CVA)
      • Evidence of end-organ ischemia
      • Ongoing chest pain/ischemic EKG changes
    • Unstable vital signs despite crystalloid bolus

Avoid overtransfusion in variceal bleeding; it can precipitate further bleeding  
  • UGIB treatment
    • IV proton pump inhibitor (PPI) (e.g., pantoprazole)
    • Octreotide for suspected variceal bleeding
    • Consider vasopressin for active variceal bleeding:
      • Bleeding cessation benefits may be counterbalanced by increased mortality due to ischemia
      • Administer with IV nitroglycerin to reduce tissue ischemia
    • High risk for active bleeding with 2 out of 3 risk factors:
      • Bright blood from NGT
      • Hemoglobin <8 g/dL
      • WBC >12,000/uL
    • Emergent endoscopy
    • Therapeutic options:
      • Cauterization of bleeding ulcers/vessels
      • Endoscopic sclerotherapy
    • Balloon tamponade with Blakemore tube is a last resort for varices
    • In cirrhotics with UGIB prophylactic antibiotic use reduce bacterial infections and all cause mortality
  • LGIB treatment
    • Consider angiography for massive, active bleeding with directed vasopressin infusion
    • Consider bowel resection for massive bleeding refractory to medical management

Medication


  • Pantoprazole: 80 mg (peds: Dosing not approved) IV bolus followed by an infusion of 8 mg/h for 72 hr
  • Octreotide: 50 μg (peds: 1-2 μg/kg) bolus, then 50 μg/h (peds: 1-2 μg/kg/h) IV
  • Somatostatin: 250 μg (peds: Not established) IV bolus and 250-500 μg/h for 2-5 days (not available in US)
  • Vasopressin: 0.4-1 IU/min (peds: 0.002-0.005 IU/kg/min) IV
  • Nitroglycerin: 10-50 μg/min (peds: Not established) IV
  • Vitamin K: 10 mg (peds: 1-5 mg) PO/SC/IV q24h

Follow-Up


Disposition


Admission Criteria
  • Active bleeding
  • Age >65 or comorbid conditions
  • Coagulopathy
  • Decreased hematocrit
  • Unstable vital signs at any time

Discharge Criteria
  • Resolution of UGIB with negative nasogastric lavage and EGD
  • Minor or resolved LGIB
  • Stable hematocrit >30 or hemoglobin >10 g/dL
  • Otherwise healthy patient

Issues for Referral
Consider referral to gastroenterologist for outpatient colonoscopy and/or EGD  

Follow-Up Recommendations


  • Patients discharged from the ED should have close follow-up within 24-36 hr
  • Give strict discharge instructions to return if further bleeding or other concerning symptoms (lightheadedness, dyspnea, chest pain, etc.) occur
  • Patients with UGIB should be discharged on a PPI, and advised to avoid caffeine, alcohol, tobacco, NSAIDs, and aspirin

Pearls and Pitfalls


  • 10-15% of UGIB present with hematochezia
  • Consider GIB in patients presenting with signs of hypovolemia or hypovolemic shock
  • Common pitfall: Failure to adequately resuscitate with crystalloid and blood products

PUD is the predominant cause of GIB in elderly and has a higher associated mortality.  

Additional Reading


  • Das  AM, Sood  N, Hodgin  K, et al. Development of a triage protocol for patients presenting with gastrointestinal hemorrhage: A prospective cohort study. Crit Care.  2008;12:R57.
  • Gralnek  IM, Barkun  AN, Bardou  M. Management of acute bleeding from a peptic ulcer. N Engl J Med.  2008;359(9):928-937.
  • Johansson  PI, Stensballe  J. Hemostatic resuscitation for massive bleeding: The paradigm of plasma and platelets-a review of the current literature. Transfusion.  2010;50(3):701-710.
  • Pallin  DJ, Saltzman  JR. Is nasogastric tube lavage in patients with acute upper GI bleeding indicated or antiquated? Gastrointest Endosc.  2011;74(5):981-984.
  • Wolfson  AB, Hendey  GW, Ling  LJ, et al., eds. Harwood-Nuss' Clinical Practice of Emergency Medicine. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.

Codes


ICD9


  • 533.40 Chronic or unspecified peptic ulcer of unspecified site with hemorrhage, without mention of obstruction
  • 535.51 Unspecified gastritis and gastroduodenitis, with hemorrhage
  • 578.9 Hemorrhage of gastrointestinal tract, unspecified
  • 562.12 Diverticulosis of colon with hemorrhage
  • 537.83 Angiodysplasia of stomach and duodenum with hemorrhage
  • 578.0 Hematemesis
  • 578.1 Blood in stool

ICD10


  • K27.4 Chronic or unsp peptic ulcer, site unsp, with hemorrhage
  • K29.71 Gastritis, unspecified, with bleeding
  • K92.2 Gastrointestinal hemorrhage, unspecified
  • K57.31 Dvrtclos of lg int w/o perforation or abscess w bleeding
  • K31.811 Angiodysplasia of stomach and duodenum with bleeding
  • K92.0 Hematemesis
  • K92.1 Melena

SNOMED


  • 74474003 Gastrointestinal hemorrhage (disorder)
  • 64121000 peptic ulcer with hemorrhage (disorder)
  • 2367005 Acute hemorrhagic gastritis (disorder)
  • 197092000 Bleeding diverticulosis (disorder)
  • 235224000 Hemorrhagic enteritis (disorder)
  • 37372002 Upper gastrointestinal hemorrhage (disorder)
  • 43935004 Vascular ectasia of gastric antrum (disorder)
  • 8765009 Hematemesis (disorder)
  • 87763006 lower gastrointestinal hemorrhage (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer